1. Home
  2. UCL vs MDXH Comparison

UCL vs MDXH Comparison

Compare UCL & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

HOLD

Current Price

$1.03

Market Cap

40.0M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.57

Market Cap

41.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCL
MDXH
Founded
2014
2003
Country
Hong Kong
Belgium
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
40.0M
41.1M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
UCL
MDXH
Price
$1.03
$0.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
13.5K
1.2M
Earning Date
05-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.60
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
$13.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.51
52 Week High
$4.19
$5.33

Technical Indicators

Market Signals
Indicator
UCL
MDXH
Relative Strength Index (RSI) 45.49 12.05
Support Level N/A N/A
Resistance Level $1.19 $3.78
Average True Range (ATR) 0.08 0.08
MACD 0.01 0.01
Stochastic Oscillator 50.00 12.57

Price Performance

Historical Comparison
UCL
MDXH

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: